[HTML] from findpharma.comRW Nims, A Chun, A Marino… - BioPharm …, 2011 - biopharminternational.findpharma. … Eukaryotic cell processes used in the manufacture of biologics are susceptible to contamination with adventitious agents. These agents include viruses, bacteria, fungi, mycoplasmas, and the so-called infectious proteins, such as transmissible spongiform encephalopathy agents. ... Related articles - Cached - All 2 versions
[HTML] from nih.govC Massire, CA Ivy, R Lovari… - Journal of clinical …, 2011 - Am Soc Microbiol ... At the same time, the spread of nontuberculosismycobacteria (NTM) infections is also emerging as an issue that must be addressed (21, 39). ... Grubek-Jaworska, H., et al. 2009. Nontuberculous mycobacterial infections among patients suspected of pulmonary tuberculosis. Eur. ... Cited by 1 - Related articles - All 4 versions
C Bicmen, AT Gunduz, M Coskun… - Journal of Clinical …, 2011 - Am Soc Microbiol ... with the clinical diagnosis have been shown in Table 3. 6 7 Nontuberculosismycobacterial test results 8 Among all samples, a total of eight nontuberculousmycobacterium species [M. 9 intracellulare (n=8), M. abscessus (n=2), M. avium (n=1), M. kansasii (n=1), M. 10 ... All 2 versions
T Koizumi, N Koshio, D Mifune… - American Journal of …, 2011 - Am Thoracic Soc Niigata Univ. Medical school, niigata, Japan, Niigata Univ. Medical school, niigata-city, Japan 1 2 ... Corresponding author's email: coix3@ma.tlp.ne.jp ... [OBJECTIVE] Non-tuberculous mycobacteria (NTM) are ubiquitous environmental organisms in contrast to those belonging to the M. ... All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
